News and Updates

Smart insulin; what is that? It’s the type of insulin that Chandra Bhattacharya, Ph.D., has spent her Breakthrough T1D-funded postdoctoral fellowship—the time right after you receive your doctoral degree, but are not ready for primetime as an assistant professor, yet—to pursue. And she has a lot of shoes to fill. At the Massachusetts Institute of […]

Shaina Hatchell discussed her children’s book “Shia Learns about Insulin," and how it can help normalize conversations about T1D for kids.

The coronavirus pandemic shuttered most camps for the summer. But with a little creativity, T1D families can enjoy a bit of the summer camp experience at home.

New, national partnership will use Breakthrough T1D’s community-facing platforms to highlight benefits of devices such as insulin pumps, continuous glucose monitors and novel treatment approaches.

During a recent Breakthrough T1D Facebook Live event, Mary Beth McNerney of Xeris Pharmaceuticals and Christine Beebe, MS, RD and Diabetes Educator discussed a new way to take charge of severe hypoglycemia episodes (“severe hypos”).  

In a victory for Breakthrough T1D’s Coverage2Control Campaign, people with T1D now have more choice in how they manage their diabetes.

Breakthrough T1D is making the following commitments internally and to the T1D community to deliver tangible results for Black Americans living with T1D.

One Night. One Community. One Purpose: to show the world the undeniable power of people living with T1D.

Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology in children ages six and older.

At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the most important topics, from artificial pancreas trials to immune therapy trials to prevention trials, all with the same goal: ending type 1 diabetes (T1D) and improving lives until that day comes. Breakthrough T1D played the […]